Accepted at 4:32 a.m. Apr, 08, 2026 by braviboron
Author: neurotherapy
Co-authors: braviboron
Related Note: 1758182835732
Rationale for change

styling: underline plus (liek othe rcards)

Text Text
Extra
Empty field
Extra (Synced)
Empty field
Personal Notes
Empty field
Missed Questions
Empty field
eTG Complete
Empty field
Talley & O'Connor
Empty field
Additional Resources
Empty field
Additional Resources (Synced)
Empty field
Source
One by one
Empty field
#Malleus_CM::#Yield::High #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Rheumatology #Malleus_CM::#Subjects::Paediatrics::02_Dermatology::Kawasaki_Disease::10_Management #Malleus_CM::#Pharmacology::21_Miscellaneous_drugs_and_late_additions::03_Immunoglobulins::Normal_immunoglobulin::03_Indications #Malleus_CM::#Pharmacology::07_Blood_and_electrolytes::02_Antiplatelets_drugs::03_Other_antiplatelet_drugs::Aspirin::03_Indications #Malleus_CM::#Subjects::Cardiology::*General::Vasculitis_Classification::Medium-Vessel_Vasculitis #Malleus_CM::#Guidelines::Australia::National::RCH_(Royal_Children's_Hospital)::K::Kawasaki_disease #Malleus_CM::#Resources_by_Rotation::Dermatology #Malleus_CM::#Subjects::Cardiology::06_Vascular_Pathology::06_Vasculitis::Kawasaki_Disease::10_Management #Malleus_CM::#Pharmacology::03_Analgesics::01_Drugs_for_pain_relief::01_Non-opioid_analgesics::Aspirin::03_Indications #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology #Malleus_CM::#Resources_by_Rotation::Paediatrics